JPRN-UMIN000034714已完成未知
Efficacy and safety of hybrid therapy combined with branched-chain amino acid and resistance training in frail patients with cardiovascular disease - Branched-chain amino acid and resistance training in frail patients with cardiovascular disease
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Dysphagia, Severe mobility limitations due to stroke or orthopedic disease, Uncontrolled cardiovascular disease, Diagnosis or treatment of cancer,Cognitive impairment; MOCA-J is above 26points, hemodialysis therapy
研究者
相似试验
已完成
不适用
Efficacy and safety of hybrid therapy combined with branched-chain amino acid and resistance training in frail CKD patients with cardiovascular diseasefrail CKD patients with cardiovascular diseaseJPRN-UMIN000034733Department of Rehabilitation, Sakakibara Heart institute90
已完成
不适用
The efficacy and safety of combination therapy of adoptive immunotherapy with chemotherapy for advanced pancreatic cancerJPRN-UMIN000011177Tokai University School of Medicine20
进行中（未招募）
不适用
COMET TrialJPRN-jRCTs031180210Yokote Koutaro60
已完成
不适用
Effectiveness and safety of Combination therapy of Ranibizumab and LuseOgliflozin in type 2 diabetes with diabetic Macular Edema, a parallel group comparison with the standard Treatment controlled by Glimepiride, multicenter, randomized, open-label trial. (COMET Trial)JPRN-UMIN000033961Chiba University60
进行中（未招募）
1 期
Safety and efficacy of combination treatment with rituximab and leflunomide in patients with active rheumatoid arthritis - Rituximab and Leflunomide in RAEUCTR2005-004582-41-GBniversity of Leeds15